These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35867610)

  • 41. Joint effects of gray matter atrophy and altered functional connectivity on cognitive deficits in amnestic mild cognitive impairment patients.
    Xie C; Bai F; Yuan B; Yu H; Shi Y; Yuan Y; Wu D; Zhang ZS; Zhang ZJ
    Psychol Med; 2015 Jul; 45(9):1799-810. PubMed ID: 25511078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Edinburgh Cognitive and Behavioural ALS Screen in a Chinese Amyotrophic Lateral Sclerosis Population.
    Ye S; Ji Y; Li C; He J; Liu X; Fan D
    PLoS One; 2016; 11(5):e0155496. PubMed ID: 27195772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study of gray matter atrophy pattern with subcortical ischemic vascular disease-vascular cognitive impairment no dementia based on structural magnetic resonance imaging.
    Tan L; Xing J; Wang Z; Du X; Luo R; Wang J; Zhao J; Zhao W; Yin C
    Front Aging Neurosci; 2023; 15():1051177. PubMed ID: 36815175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regional Gray Matter Atrophy in Vascular Mild Cognitive Impairment.
    Lei Y; Su J; Guo Q; Yang H; Gu Y; Mao Y
    J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):95-101. PubMed ID: 26432563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson's disease.
    Inguanzo A; Sala-Llonch R; Segura B; Erostarbe H; Abos A; Campabadal A; Uribe C; Baggio HC; Compta Y; Marti MJ; Valldeoriola F; Bargallo N; Junque C
    Parkinsonism Relat Disord; 2021 Jan; 82():16-23. PubMed ID: 33227683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cognition and gray and white matter characteristics of presymptomatic
    Papma JM; Jiskoot LC; Panman JL; Dopper EG; den Heijer T; Donker Kaat L; Pijnenburg YAL; Meeter LH; van Minkelen R; Rombouts SARB; van Swieten JC
    Neurology; 2017 Sep; 89(12):1256-1264. PubMed ID: 28855404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The structural changes of gray matter in Parkinson disease patients with mild cognitive impairments.
    Li L; Ji B; Zhao T; Cui X; Chen J; Wang Z
    PLoS One; 2022; 17(7):e0269787. PubMed ID: 35857782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional reorganization during cognitive function tasks in patients with amyotrophic lateral sclerosis.
    Keller J; Böhm S; Aho-Özhan HEA; Loose M; Gorges M; Kassubek J; Uttner I; Abrahams S; Ludolph AC; Lulé D
    Brain Imaging Behav; 2018 Jun; 12(3):771-784. PubMed ID: 28600740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brain positron emission tomography in patients with myotonic dystrophy type 1 and type 2.
    Peric S; Brajkovic L; Belanovic B; Ilic V; Salak-Djokic B; Basta I; Rakocevic Stojanovic V
    J Neurol Sci; 2017 Jul; 378():187-192. PubMed ID: 28566162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gray matter atrophy in patients with Parkinson's disease and those with mild cognitive impairment: a voxel-based morphometry study.
    Zhang J; Zhang YT; Hu WD; Li L; Liu GY; Bai YP
    Int J Clin Exp Med; 2015; 8(9):15383-92. PubMed ID: 26629027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study.
    Gliem C; Minnerop M; Roeske S; Gärtner H; Schoene-Bake JC; Adler S; Witt JA; Hoffstaedter F; Schneider-Gold C; Betz RC; Helmstaedter C; Tittgemeyer M; Amunts K; Klockgether T; Weber B; Kornblum C
    PLoS One; 2019; 14(3):e0213381. PubMed ID: 30845252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.
    Vipin A; Wong BYX; Kumar D; Low A; Ng KP; Kandiah N
    Aging (Albany NY); 2021 Apr; 13(8):10973-10988. PubMed ID: 33861727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease.
    Minnerop M; Weber B; Schoene-Bake JC; Roeske S; Mirbach S; Anspach C; Schneider-Gold C; Betz RC; Helmstaedter C; Tittgemeyer M; Klockgether T; Kornblum C
    Brain; 2011 Dec; 134(Pt 12):3530-46. PubMed ID: 22131273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients.
    Kalinowska-Łyszczarz A; Pawlak MA; Pietrzak A; Pawlak-Buś K; Leszczyński P; Puszczewicz M; Majewski D; Paprzycki W; Kozubski W; Michalak S
    Lupus; 2018 Apr; 27(4):610-620. PubMed ID: 28992796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gray matter atrophy in patients with ischemic stroke with cognitive impairment.
    Stebbins GT; Nyenhuis DL; Wang C; Cox JL; Freels S; Bangen K; deToledo-Morrell L; Sripathirathan K; Moseley M; Turner DA; Gabrieli JD; Gorelick PB
    Stroke; 2008 Mar; 39(3):785-93. PubMed ID: 18258824
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regional cingulum disruption, not gray matter atrophy, detects cognitive changes in amnestic mild cognitive impairment subtypes.
    Chang YL; Chen TF; Shih YC; Chiu MJ; Yan SH; Tseng WY
    J Alzheimers Dis; 2015; 44(1):125-38. PubMed ID: 25190630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study.
    Damjanovic D; Valsasina P; Rocca MA; Stromillo ML; Gallo A; Enzinger C; Hulst HE; Rovira A; Muhlert N; De Stefano N; Bisecco A; Fazekas F; Arévalo MJ; Yousry TA; Filippi M
    AJNR Am J Neuroradiol; 2017 Jan; 38(1):18-24. PubMed ID: 27686487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2.
    Peric S; Mandic-Stojmenovic G; Stefanova E; Savic-Pavicevic D; Pesovic J; Ilic V; Dobricic V; Basta I; Lavrnic D; Rakocevic-Stojanovic V
    J Neurol; 2015 Jan; 262(1):142-8. PubMed ID: 25346064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Grey matter atrophy in mild cognitive impairment / early Alzheimer disease associated with delusions: a voxel-based morphometry study.
    Ting WK; Fischer CE; Millikin CP; Ismail Z; Chow TW; Schweizer TA
    Curr Alzheimer Res; 2015; 12(2):165-72. PubMed ID: 25654501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clusters of cognitive impairment among different phenotypes of myotonic dystrophy type 1 and type 2.
    Peric S; Rakocevic Stojanovic V; Mandic Stojmenovic G; Ilic V; Kovacevic M; Parojcic A; Pesovic J; Mijajlovic M; Savic-Pavicevic D; Meola G
    Neurol Sci; 2017 Mar; 38(3):415-423. PubMed ID: 27896491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.